A New Disruption In Wellness: dLife Promises Reversal Of Type 2 Diabetes, PCOS And NAFLD Or Refund
Updated On: 13 March, 2026 12:47 PM IST | Mumbai | Buzz
dLife challenges conventional care by focusing on insulin resistance and metabolic correction for diabetes, PCOS and fatty liver.

dLife
The focus shifts from calorie counting and gym routines to correcting insulin resistance and stabilising blood sugar
India’s chronic lifestyle disease management playbook has traditionally focused on lifelong management through medicines and medical procedures. Patients are advised to control their numbers, stay on medication, and accept metabolic conditions as permanent. So much so that Type 2 diabetes is labelled as a progressive disease, and diseases like NAFLD, PCOS are normalized - “Sabko hota hai” is the verdict.

